News – Page 87 – Boston Harbor Angels

20MayMay 20, 2020

Interview with John O’Neil, Chief Scientific Officer of Xylyx

An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O’Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting, and tissue engineering. Read more >>

Portfolio NewsXylyx Bio

20MayMay 20, 2020

Three Investors Offer Fundraising Tips for Early-stage Startups

Three early-stage investors spoke with the Greentown Labs community this month about different types of investors, how to build investor relationships, and advice for approaching fundraising in an uncertain economy. The panel, which was part of Greentown’s Investor Speaker Series, featured Deb Kemper, managing partner of Golden Seeds Ventures, Christopher Mirabile, chair emeritus and public policy chair emeritus of the Angel Capital Association, and Ziad H. Moukheiber, president and CEO of Boston Harbor Angels. Read more >>

Member NewsZiad Moukheiber

19MayMay 19, 2020

The Evolution of Premium Canned Wine

Canned wine isn’t just found on grocery store shelves and at outdoor festivals these days...An increasing awareness of sustainability and wellness among consumers may bolster the positioning of premium canned wine in the marketplace. Organic farming and energy conservation are integral to the philosophy behind canned wine brand Archer Roose, founded in 2015, as does the aluminum package. Read more >>

Portfolio NewsArcher Roose

19MayMay 19, 2020

Aircuity announces new vice president of operations

Aircuity in Newton announced that Tom Nasti joined the company as the vice president of operations. Read more >>

Portfolio NewsAircuity

15MayMay 15, 2020

Cruising along: 5 tech firms that are thriving in the pandemic

Wasabi on list. Read more >>

Portfolio NewsWasabi

15MayMay 15, 2020

Collaborating on Rare Disease R&D

This week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn of Corbus Pharmaceuticals’ collaboration with University of Pennsylvania on a Phase 2 study, which has shown positive results. Read more >>

Portfolio NewsCorbus Pharmaceuticals

14MayMay 14, 2020

CytoAgents Receives NIH Funding to Accelerate Treatment for Cytokine Storm

CytoAgents awarded $1.6 million National Institutes of Health (NIH) grant to accelerate treatment for cytokine storm. Read more >>

Portfolio NewsCytoAgents

13MayMay 13, 2020

Premama Wellness raises $3.5M in first institutional funding round

Premama Wellness, a Providence-based startup that sells supplements for maternity wellness, has attracted its first institutional investor since launching in 2011: District Ventures Capital, a Canadian venture capital fund hyper-focused on the food, beverage and health and wellness sectors. Read more >>

Portfolio NewsPremama

08MayMay 8, 2020

Emovi Selected by the Consulate General of Canada in Boston, to Join the 2020 Cohort for the Canadian Technology Accelerator

Emovi, Inc., a Canadian medical device company, announced today that they were selected to join the Canadian Technology Accelerator (CTA) in Boston, MA. Emovi was selected with 10 other companies to participate in the 2020 cohort. Read more >>

Portfolio NewsEmovi

06MayMay 6, 2020

Hoth Therapeutics Expands Partnership with Zylö Therapeutics, Inc.

Hoth Therapeutics, Inc., a biopharmaceutical company, today announced it has completed a strategic investment in Zylö Therapeutics, Inc. Mr. Robb Knie, Chief Executive Officer of Hoth, commented, "We are pleased to expand our partnership with Zylö and look forward to working together as our therapeutic for Lupus patients continues through the next phase of development. Read more >>

Portfolio NewsZylö Therapeutics